Healthdirect Free Australian health advice you can count on.

Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately

healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.

beginning of content

Brand name: Xeloda

Xeloda is a medicine containing the active ingredient(s) capecitabine. On this page you will find out more about Xeloda, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.

Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.

Active ingredient in this medicine: capecitabine

Information for medicine and pack size:
Xeloda 500 mg film-coated tablet, 120

Consumer Medicine Information leaflet:

This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.

Read leaflet

What this medicine is for

Colon Cancer Xeloda is indicated for the adjuvant treatment of patients with Dukes? stage C and high-risk stage B colon cancer, either as monotherapy or in combination with oxaliplatin. Colorectal Cancer Xeloda is indicated for the treatment of advanced or metastatic colorectal cancer. Oesophagogastric Cancer Xeloda is indicated for the first-line treatment of patients with advanced oesophagogastric cancer in combination with a platinum-based regimen. Breast Cancer Xeloda is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of taxanes and an anthracycline containing chemotherapy regimen unless therapy with these and other standard agents are clinically contraindicated. Xeloda in combination with docetaxel is indicated for the treatment of patients with locally advanced or metastatic breast cancer after failure of prior anthracycline containing chemotherapy

Table of characteristics
Table of characteristics
Active ingredient
Visual appearance Biconvex film-coated oblong-shaped tablet with "XELODA" engraved on one face and "500" engraved on the reverse. The tablet is peach coloured.

Images are the copyright of the Pharmacy Guild of Australia

Dosage Form Tablet, film coated
Route of administration Oral
Medicine schedule
120 tablets: Prescription Only Medicine, or Prescription Animal Remedy

There is one type of pack available.

Pack type 1
Pack type 1
Type Blister Pack
Storage temperature Store below 30 degrees Celsius
Storage conditions No information available
Life time 2 Years
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 November 2017

The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.

Go to PBS site

Is this medication banned in sport?

Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.

Go to ASADA site

The information displayed on this page is authored by Healthdirect Australia, or obtained from trusted sources.

Need more information?

These trusted information partners have more on this topic.

Found 5 results

Xeloda Tablets - myDr.com.au

Xeloda Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Xeloda (capecitabine) information | myVMC

Xeloda (capecitabine) is an anti-neoplastic agent used to treat cancer of the bowel and rectum (colorectal), breast and stomach and food pipe (oesophagus).

Read more on myVMC – Virtual Medical Centre website

Chemotherapy | myVMC

Chemotherapry treatment and side effects information on chemotherapy and cancer drug medical treatment news.

Read more on myVMC – Virtual Medical Centre website

Tykerb Tablets - myDr.com.au

Tykerb Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Nexavar Tablets - myDr.com.au

Nexavar Tablets - Consumer Medicines Information leaflets of prescription and over-the-counter medicines

Read more on myDr – Consumer Medicine Information website

Check your symptoms Find a health service

Healthdirect 24hr 7 days a week hotline

24 hour health advice and information you can count on

1800 022 222

Government Accredited with over 140 information partners

We are a government-funded service, providing quality, approved health information

Australian Government, health department logo ACT Government logo New South Wales government, health department logo Northen Territory Government logo Government of South Australia, health department logo Tasmanian government logo Government of Western Australia, health department logo
Feedback